Companies / Health Care / Pharmaceuticals
Viatris stock buybacks
VTRS$303Mbought back in the 12 months to Jun 30, 2026
Viatris bought back $303M of its stock in the last twelve months, $131M more than it paid out in stock compensation. Its share count is down 0.8% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q1 '22 | $0 |
| Q2 '22 | $0 |
| Q3 '22 | $0 |
| Q4 '22 | $0 |
| Q1 '23 | $250M |
| Q2 '23 | $0 |
| Q3 '23 | $0 |
| Q4 '23 | $0 |
| Q1 '24 | $250M |
| Q2 '24 | $0 |
| Q3 '24 | $0 |
| Q4 '24 | $0 |
| Q1 '25 | $175.4M |
| Q2 '25 | $175M |
| Q3 '25 | $67.9M |
| Q4 '25 | $85.1M |
| Q1 '26 | $0 |
| Q2 '26 | $150M |
Show as table
| Period | Value |
|---|---|
| Q1 '22 | 1.21B |
| Q2 '22 | 1.22B |
| Q3 '22 | 1.22B |
| Q4 '22 | 1.22B |
| Q1 '23 | 1.21B |
| Q2 '23 | 1.20B |
| Q3 '23 | 1.21B |
| Q4 '23 | 1.21B |
| Q1 '24 | 1.21B |
| Q2 '24 | 1.19B |
| Q3 '24 | 1.20B |
| Q1 '25 | 1.19B |
| Q2 '25 | 1.17B |
| Q3 '25 | 1.16B |
| Q1 '26 | 1.18B |
| Q2 '26 | 1.16B |
$150Mlast quarter (Q2 2026)
$131Mnet of stock compensation ($172M)
−0.8%diluted shares, 1 year
+133.7%diluted shares, 5 years
$0dividends, 12 months
16%of free cash flow ($2.0B) spent on buybacks
$3Mraised by issuing stock, 12 months
1.15Bshares outstanding (Aug 3, 2026)
By fiscal year
Questions
- Does Viatris buy back its stock?
- Viatris bought back $303M of its stock in the last twelve months, $131M more than it paid out in stock compensation. Its share count is down 0.8% from a year earlier.
- How much did Viatris spend on buybacks in fiscal 2025?
- $501M, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Viatris's share count going down?
- Its diluted share count changed +133.7% over five fiscal years and −0.8% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 6, 2026 · open on SEC.gov